Background pattern

APIXABAN TORRENT 5 mg FILM-COATED TABLETS

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use APIXABAN TORRENT 5 mg FILM-COATED TABLETS

Introduction

Package Leaflet: Information for the User

Apixaban Torrent 5mg film-coated tablets EFG

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What is Apixaban Torrent and what is it used for
  2. What you need to know before you take Apixaban Torrent
  3. How to take Apixaban Torrent
  4. Possible side effects
  5. Storing Apixaban Torrent
  6. Contents of the pack and further information

1. What is Apixaban Torrent and what is it used for

This medicine contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent the formation of blood clots by blocking Factor Xa, an important element in the blood clotting process.

Apixaban is used in adults:

  • to prevent the formation of a blood clot in the heart in patients with an irregular heartbeat (atrial fibrillation) and at least one additional risk factor. Blood clots can break loose, move to the brain, and cause a stroke, or move to other organs, preventing proper irrigation of the organ (also known as systemic embolism). A stroke can be life-threatening and requires immediate medical attention.
  • to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), and to prevent these blood clots from recurring in the blood vessels of the legs and/or lungs.

2. What you need to know before you take Apixaban Torrent

  • is allergicto apixaban or any of the other ingredients of this medicine (listed in section 6);
  • bleeds excessively;
  • has a disease in an organof the body that increases the risk of severe bleeding (such as an active or recent ulcerof the stomach or intestine, or recent cerebral hemorrhage);
  • has a liver diseasethat increases the risk of bleeding (hepatic coagulopathy);
  • is taking medicines to prevent blood clotting(e.g., warfarin, rivaroxaban, dabigatran, or heparin), except when switching treatment, while having an arterial or venous line and being treated with heparin to keep the line open, or when a tube is inserted into a blood vessel (catheter ablation) to treat an irregular heartbeat (arrhythmia).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before taking this medicine if you have any of these conditions:

  • an increased risk of bleeding, such as:
  • bleeding disorders, including situations that result in a decrease in platelet activity;
  • very high blood pressure, not controlled by medical treatment;
  • you are over 75 years old;
  • you weigh 60 kg or less;
  • a severe kidney disease or if you are on dialysis;
  • a liver problem or history of liver problems;

This medicine will be used with caution in patients with signs of altered liver function

  • you have a heart valve prosthesis;
  • if your doctor determines that your blood pressure is unstable or you are scheduled to receive another treatment or undergo surgery to remove the blood clot from your lungs.

Be careful with Apixaban

  • if you know you have a disease called antiphospholipid syndrome (an immune system disorder that increases the risk of blood clots), inform your doctor to decide if it may be necessary to modify the treatment.

If you need to undergo surgery or a procedure that may cause bleeding, your doctor will tell you to temporarily stop taking this medicine for a while. If you are not sure if a procedure may cause bleeding, talk to your doctor.

Children and adolescents

This medicine is not recommended for use in children and adolescents under 18 years of age.

Other medicines and Apixaban Torrent

Tell your doctor, pharmacist, or nurse if you are using, have recently used, or might use other medicines.

Some medicines may increase the effects of apixaban, and some medicines may decrease its effects. Your doctor will decide if you should be treated with apixaban if you are taking these medicines and if you should be kept under closer observation.

The following medicines may increase the effects of apixaban and increase the possibility of an unwanted hemorrhage:

  • some medicines for fungal infections(e.g., ketoconazole, etc.);
  • some antiviral medicines for HIV/AIDS(e.g., ritonavir);
  • other medicines to reduce blood clotting(e.g., enoxaparin, etc.);
  • anti-inflammatoryor pain-relieving medicines(e.g., acetylsalicylic acid or naproxen). Especially if you are over 75 years old and taking acetylsalicylic acid, there is a higher probability of bleeding;
  • medicines for high blood pressure or heart problems(e.g., diltiazem);
  • antidepressantscalled selective serotonin reuptake inhibitorsor serotonin-noradrenaline reuptake inhibitors.

The following medicines may reduce the ability of apixaban to prevent blood clot formation:

  • medicines for the treatment of epilepsy or convulsions(e.g., phenytoin, etc.);
  • St. John's Wort(a herbal medicine for the treatment of depression);
  • medicines for the treatment of tuberculosisor other infections(e.g., rifampicin).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before taking this medicine.

The effects of apixaban on pregnancy and the fetus are not known. You should not take this medicine if you are pregnant. Tell your doctor immediatelyif you become pregnant while taking this medicine.

It is not known whether apixaban is excreted in human milk. Ask your doctor, pharmacist, or nurse for advice before taking this medicine during breastfeeding. They will tell you whether to stop breastfeeding or whether to stop or not start taking this medicine.

Driving and using machines

Apixaban has no influence on the ability to drive or use machines.

Apixaban Torrent contains lactose

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Apixaban Torrent contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".

3. How to take Apixaban Torrent

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are unsure, talk to your doctor, pharmacist, or nurse.

Dosage

Take the tablet with water. This medicine can be taken with or without food.

Try to take the tablets at the same time each day to achieve a better treatment effect.

If you have difficulty swallowing the tablet whole, talk to your doctor about other possible ways to take apixaban. The tablet can be crushed and mixed with water, 5% glucose in water, apple juice, or apple puree, immediately before taking it.

Instructions for crushing:

  • Crush the tablets with a mortar.
  • Carefully transfer all the powder into a suitable container, mixing the powder with a small amount, e.g., 30 ml (2 tablespoons), of water or any of the other liquids mentioned to make the mixture.
  • Take the mixture.
  • Rinse the mortar and pestle used to crush the tablet and the container with a small amount of water or one of the other liquids (e.g., 30 ml), and take that liquid.

If necessary, your doctor may also administer the crushed apixaban tablet mixed in 60 ml of water or 5% glucose in water through a nasogastric tube.

Take Apixaban Torrent according to the following recommendations:

To prevent the formation of a blood clot in the heart in patients with an irregular heartbeat and at least one additional risk factor.

The recommended dose of apixaban is one tabletof apixaban 5mgtwice a day.

The recommended dose is one tabletof apixaban 2.5mgtwice a day if:

  • you have severely reduced kidney function;
  • two or more of the following factors apply to you:
    • your blood test results suggest poor kidney function (the serum creatinine value is 1.5 mg/dl (133 micromoles/l) or higher);
    • you are 80 years old or older;
    • your weight is 60 kg or less.

The recommended dose is one tablettwice a day, for example, take one tablet in the morning and one in the evening. Your doctor will tell you how long to continue the treatment.

To treat blood clots in the veins of the legs and in the blood vessels of the lungs

The recommended dose is two tabletsof apixaban 5mgtwice a day for the first 7 days, for example, two tablets in the morning and two tablets in the evening.

After 7 days, the recommended dose is one tabletof apixaban 5mgtwice a day, for example, one tablet in the morning and one in the evening.

To prevent blood clots from recurring after 6 months of treatment

The recommended dose is one tabletof apixaban 2.5mgtwice a day, for example, one tablet in the morning and one in the evening.

Your doctor will tell you how long to continue the treatment.

Your doctor may change your anticoagulant treatment as follows:

  • Switching from apixaban to anticoagulant medicines

Stop taking apixaban. Start treatment with anticoagulant medicines (e.g., heparin) at the time you would take the next tablet.

  • Switching from anticoagulant medicines to apixaban

Stop taking anticoagulant medicines. Start treatment with apixabanat the time you would take the next dose of an anticoagulant medicine, and then continue as usual.

  • Switching from a treatment with anticoagulants that contain vitamin K antagonists (e.g., warfarin) to apixaban

Stop taking the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to start taking apixaban.

  • Switching from apixaban to a treatment with anticoagulants that contain vitamin K antagonists (e.g., warfarin).

If your doctor tells you to start taking a medicine that contains a vitamin K antagonist, continue taking apixaban for at least 2 days after your first dose of the medicine that contains a vitamin K antagonist. Your doctor will need to perform blood tests and tell you when to stop taking apixaban.

Patients undergoing cardioversion

If your heartbeat needs to be restored through a process called cardioversion, take this medicine at the times your doctor indicates to prevent blood clots in the blood vessels of the brain and other blood vessels in the body.

If you take more Apixaban than you should

Tell your doctor immediatelyif you have taken a dose greater than the prescribed dose of this medicine. Take the package of the medicine to your doctor, even if there are no tablets left.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.

If you take more apixaban than the recommended dose, you may increase the risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that can reverse anti-factor Xa activity may be necessary.

If you forget to take Apixaban Torrent

  • Take the dose as soon as you remember and:
  • take the next dose of apixaban at the usual time
  • then continue taking the medicine as usual.

If you have doubts about what to do or if you forget to take more than one dose,ask your doctor, pharmacist, or nurse.

If you stop taking Apixaban Torrent

Do not stop taking this medicine without talking to your doctor first, because the risk of developing a blood clot may be greater if you stop treatment too soon.

If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. The most frequent adverse effect of this medicine is bleeding, which can put the patient's life at risk and requires immediate medical attention.

The following adverse effects have been reported when taking apixaban to prevent the formation of blood clots in the heart in patients with irregular heart rhythm and at least one additional risk factor.

Frequent Adverse Effects (may affect up to 1 in 10 people)

  • Bleeding, including:
  • in the eyes;
  • in the stomach or intestine;
  • from the rectum;
  • blood in the urine;
  • from the nose;
  • from the gums;
  • bruising and swelling;
  • Anemia, which can cause fatigue or paleness;
  • Low blood pressure, which can cause fainting or a faster heart rate;
  • Nausea (general discomfort);
  • Blood tests may show:
  • an increase in gamma glutamyl transferase (GGT).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

  • Bleeding:
  • in the brain or spinal cord;
  • in the mouth or coughing up blood;
  • in the abdomen, or vagina;
  • bright red blood in the stool;
  • bleeding after surgery, including bruising and swelling, discharge of blood or fluid from the wound/surgical incision (suppuration) or at the injection site;
  • hemorrhoidal;
  • tests showing blood in the stool or urine;
  • Decreased platelet count in the blood (which can affect coagulation);
  • Blood tests may show:
  • abnormal liver function;
  • increased liver enzymes;
  • increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes;
  • Skin rash;
  • Itching;
  • Hair loss;
  • Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Inform your doctor immediatelyif you experience any of these symptoms.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

  • Bleeding:
  • in the lungs or throat;
  • in the space behind the abdominal cavity;
  • in a muscle.

Very Rare Adverse Effects (may affect up to 1 in 10,000 people)

  • Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme).

Frequency Not Known (cannot be estimated from available data)

  • Inflammation of blood vessels (vasculitis) that can cause skin rash, appearance of red round and smooth spots under the skin surface or bruising.
  • Bleeding in the kidney, sometimes with blood in the urine, which can cause the kidneys to fail to function properly (anticoagulant-related nephropathy).

The following adverse effects have been reported when taking apixaban to treat or prevent blood clots from recurring in the veins of the legs and in the blood vessels of the lungs.

Frequent Adverse Effects (may affect up to 1 in 10 people)

  • Bleeding, including:
  • from the nose;
  • from the gums;
  • blood in the urine;
  • bruising and swelling;
  • from the stomach, intestine, or rectum;
  • in the mouth;
  • vaginal;
  • Anemia, which can cause fatigue or paleness;
  • Decreased platelet count in the blood (which can affect coagulation);
  • Nausea (general discomfort);
  • Skin rash;
  • Blood tests may show:
  • an increase in gamma glutamyl transferase (GGT) or alanine aminotransferase (GPT).

Uncommon Adverse Effects (may affect up to 1 in 100 people)

  • Low blood pressure, which can cause fainting or a faster heart rate
  • Bleeding:
  • in the eyes;
  • in the mouth or coughing up blood;
  • bright red blood in the stool;
  • tests showing blood in the stool or urine;
  • bleeding after surgery, including bruising and swelling, discharge of blood or fluid from the wound/surgical incision (suppuration); or at the injection site;
  • hemorrhoidal;
  • in a muscle;
  • Itching;
  • Hair loss;
  • Allergic reactions (hypersensitivity) that can cause: swelling of the face, lips, mouth, tongue, and/or throat, and difficulty breathing. Contact your doctor immediatelyif you experience any of these symptoms.
  • Blood tests may show:
  • abnormal liver function;
  • increased liver enzymes;
  • increased bilirubin, a byproduct of red blood cells, which can cause yellowing of the skin and eyes.

Rare Adverse Effects (may affect up to 1 in 1,000 people)

  • Bleeding:
  • in the brain or spinal cord;
  • in the lungs.

Frequency Not Known (cannot be estimated from available data)

  • Bleeding:
  • in the abdomen or the space behind the abdominal cavity.
  • Skin rash that can form blisters and resemble small targets (dark spots in the center surrounded by a paler area, with a dark ring around) (erythema multiforme);
  • Inflammation of blood vessels (vasculitis) that can cause skin rash, appearance of red round and smooth spots under the skin surface or bruising.
  • Bleeding in the kidney, sometimes with blood in the urine, which can cause the kidneys to fail to function properly (anticoagulant-related nephropathy).

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Apixaban Torrent

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the carton and on each blister, after EXP. The expiration date is the last day of the month indicated.

This medicine does not require special storage conditions.

Bottles of 60 tablets:

This medicine should not be used after 30 days of first opening.

Bottles of 500 tablets:

This medicine should not be used after 90 days of first opening.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of unused medicines. This will help protect the environment.

6. Package Contents and Additional Information

Composition of Apixaban Torrent

  • The active ingredient is apixaban.

Each tablet contains 5 mg of apixaban.

  • The other ingredients are:
  • Core of the tablet: anhydrous lactose, microcrystalline cellulose, sodium lauryl sulfate, sodium croscarmellose, magnesium stearate.
  • Coating: hypromellose (E464), lactose monohydrate, titanium dioxide (E171), triacetin, red iron oxide (E172).

Appearance of the Product and Package Contents

The 5 mg tablets are pink, oval, biconvex, with beveled edges and "H5" engraved on one face and smooth on the other face.

They are presented in Al-Al blisters within cartons containing 20 or 200 film-coated tablets or in HDPE bottles with child-resistant/continuous thread closure and induction seal containing 60 or 500 film-coated tablets.

Only certain pack sizes may be marketed.

Patient Information Card:

Inside the package of this medicine, along with the leaflet, you will find a Patient Information Card or your doctor may give you a similar card.

This Patient Information Card includes useful information for you and will alert other doctors that you are being treated with apixaban. Always carry this card with you.

  1. Take the card.
  2. Separate the language you need (this is facilitated through the perforated ends).
  3. Complete the following sections or ask your doctor to complete them:
  • Name:
  • Date of birth:
  • Indication:
  • Dose: ........mg twice a day
  • Doctor's name:
  • Doctor's phone number:
  1. Fold the card and carry it with you at all times

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Torrent Pharma (Malta) Ltd.

Vault 14, Level 2, Valletta waterfront,

Floriana FRN 1914,

Malta

Manufacturer

Torrent Pharma (Malta) Ltd

Central Business Centre, Level 2,

Triq Hal Tarzien, Il

Gudja GDJ 1907

Malta

Pharmadox Healthcare Ltd.

KW20A Kordin Industrial Park,

Paola, PLA3000,

Malta

Interpharma Services Ltd.

43A Cherni Vrach Blvd,

1407 Sofia,

Bulgaria

Misom Labs Ltd.,

Malta Life Sciences Park,

LS2.01.06, Industrial Estate,

San Gwann, SGN 3000,

Malta

Date of Last Revision of this LeafletMay 2025

Other Sources of Information

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe